Read in
CAIRO — The number of counterfeit medications in Egyptian markets has recently reached 30% of the total of drugs on the market. The prevalence of counterfeit drugs has even extended to several vital medications used to treat cancer, liver inflammation, allergies, diabetes and tumors.
The consumer, torn between the Ministry of Health, the police and the Ministry of Supply, remains the biggest victim, in the absence of an independent Egyptian drug committee that monitors the registration, pricing, sale and quality control of medications. Egypt’s national economy is suffering as well.
